Makers of OxyContin to Pay $270 Million in Oklahoma Opioid Lawsuit

Purdue Pharma, the maker of OxyContin, has agreed to a $270 million settlement in a lawsuit brought by the Oklahoma attorney general, according to CNN. The New York Times reports that this settlement is considerably higher than those of earlier lawsuits in different states, including a settlement between Purdue Pharma and Kentucky of $24 million in 2015.

Purdue Pharma was accused of deceptive marketing and aggressive promotion that downplayed the OxyContin’s addictive properties. The settlement comes two months before the scheduled trial date at the end of May, in which the trial was to be televised in Oklahoma, as NBC News explains in its coverage of the lawsuit. The New York Times gives context:

But the settlement also means that the public will not hear a full recounting of Purdue’s actions in promoting OxyContin to doctors and underplaying its addictive properties, including testimony by members of the Sackler family.

See doctors who help treat opioid dependence in Oklahoma City.

Articles
Finding Suboxone Clinic That Takes Insurance Near YouThe Importance of Family Therapy in Drug Abuse TreatmentDetoxing from Drugs: Common Symptoms and How to Manage ThemThe Role of Suboxone Doctors in Opioid Addiction Recovery    Talking to Your Doctor About Substance Use Disorder
More Articles
I NEED TO TALK TO SOMEONE NOWConsidering Recovery? Talk to a Treatment Specialist: 888-844-3455Response time about 1 min | Response rate 100%
Who Answers?
Close
Buprenorphine Doctors
x

Who Answers this Call?

This phone line is answered by Compass Hotline, which is sponsored by Compass Detox, our drug and alcohol addiction treatment facility sponsor.

To discover alternative addiction treatment options, please visit the Substance Abuse and Mental Health Services Administration Treatment Locator the National Institute on Alcohol Abuse and Alcoholism Alcohol Treatment Navigator.